PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TGTX vs. RYTM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


TGTXRYTM
YTD Return79.98%42.66%
1Y Return200.78%130.43%
3Y Return (Ann)-1.11%71.25%
5Y Return (Ann)31.34%25.55%
Sharpe Ratio2.972.52
Sortino Ratio3.603.08
Omega Ratio1.451.37
Calmar Ratio2.044.42
Martin Ratio10.628.97
Ulcer Index19.12%15.99%
Daily Std Dev68.43%56.84%
Max Drawdown-99.99%-92.10%
Current Drawdown-98.44%-2.60%

Fundamentals


TGTXRYTM
Market Cap$4.79B$4.03B
EPS-$0.10-$4.32
Total Revenue (TTM)$264.79M$112.53M
Gross Profit (TTM)$233.60M$99.35M
EBITDA (TTM)$2.41M-$259.92M

Correlation

-0.50.00.51.00.3

The correlation between TGTX and RYTM is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

TGTX vs. RYTM - Performance Comparison

In the year-to-date period, TGTX achieves a 79.98% return, which is significantly higher than RYTM's 42.66% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%JuneJulyAugustSeptemberOctoberNovember
77.48%
63.13%
TGTX
RYTM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TGTX vs. RYTM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TGTX
Sharpe ratio
The chart of Sharpe ratio for TGTX, currently valued at 2.97, compared to the broader market-4.00-2.000.002.004.002.97
Sortino ratio
The chart of Sortino ratio for TGTX, currently valued at 3.60, compared to the broader market-4.00-2.000.002.004.006.003.60
Omega ratio
The chart of Omega ratio for TGTX, currently valued at 1.45, compared to the broader market0.501.001.502.001.45
Calmar ratio
The chart of Calmar ratio for TGTX, currently valued at 2.50, compared to the broader market0.002.004.006.002.50
Martin ratio
The chart of Martin ratio for TGTX, currently valued at 10.62, compared to the broader market0.0010.0020.0030.0010.62
RYTM
Sharpe ratio
The chart of Sharpe ratio for RYTM, currently valued at 2.52, compared to the broader market-4.00-2.000.002.004.002.52
Sortino ratio
The chart of Sortino ratio for RYTM, currently valued at 3.08, compared to the broader market-4.00-2.000.002.004.006.003.08
Omega ratio
The chart of Omega ratio for RYTM, currently valued at 1.37, compared to the broader market0.501.001.502.001.37
Calmar ratio
The chart of Calmar ratio for RYTM, currently valued at 4.42, compared to the broader market0.002.004.006.004.42
Martin ratio
The chart of Martin ratio for RYTM, currently valued at 8.97, compared to the broader market0.0010.0020.0030.008.97

TGTX vs. RYTM - Sharpe Ratio Comparison

The current TGTX Sharpe Ratio is 2.97, which is comparable to the RYTM Sharpe Ratio of 2.52. The chart below compares the historical Sharpe Ratios of TGTX and RYTM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
2.97
2.52
TGTX
RYTM

Dividends

TGTX vs. RYTM - Dividend Comparison

Neither TGTX nor RYTM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TGTX vs. RYTM - Drawdown Comparison

The maximum TGTX drawdown since its inception was -99.99%, which is greater than RYTM's maximum drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for TGTX and RYTM. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-44.01%
-2.60%
TGTX
RYTM

Volatility

TGTX vs. RYTM - Volatility Comparison

TG Therapeutics, Inc. (TGTX) has a higher volatility of 20.16% compared to Rhythm Pharmaceuticals, Inc. (RYTM) at 16.96%. This indicates that TGTX's price experiences larger fluctuations and is considered to be riskier than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
20.16%
16.96%
TGTX
RYTM

Financials

TGTX vs. RYTM - Financials Comparison

This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items